The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

The White House on Friday said Novo Nordisk’s weight-loss drugs Wegovy and Ozempic were among the 15 medications picked for a ...

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

Ozempic, Zepbound, Wegovy, and other GLP-1 medications have transformed the way we lose weight. People who take them report life-changi ...

The European Union has a plan for dealing with increasing cyberattacks against hospitals in its member countries.

Noom releases a significant update of its innovative GLP-1 companion to improve medication persistence and adherence while decreasing side effect ...

Reverse Health has created a 12-week programme specifically for women over 40 who are struggling to lose weight ...

Sales of blockbuster weight-loss drugs have surged in 2024 and are projected to continue rising in the coming years. The ...

These food trackers can help you follow a healthy eating plan, teach you to make smarter food choices and assist in weight ...